PhRMA says the proposals are aimed at modernizing the drug discovery and development process, promoting value-driven health care, engaging and empowering consumers, and addressing market distortions.
During the Pharmaceutical Research and Manufacturers of America (PhRMA) 2016 Annual Meeting on March 10, 2016, PhRMA president and CEO Stephen J. Ubl announced the association’s policy solutions for delivering innovative treatments to patients. The organization said in a press announcement the proposals in the policy framework are aimed at modernizing the drug discovery and development process, promoting value-driven healthcare, engaging and empowering consumers, and addressing market distortions.
“We need to improve on the competitive market to build a sustainable health care system that stems the growth of chronic disease and fosters the development of tomorrow’s cures,” Ubl said in a press announcement.
PhRMA’s new policy solutions include:
Source: PhRMA
New Cancer Research and Treatment Center in Development in London
May 1st 2025Aviva Capital Partners and developer Socius are investing £1 billion in a 12-acre site to be located at the London Cancer Hub next to The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust’s Sutton site.